Literature DB >> 19201427

The management of thyroid nodules in patients with primary hyperparathyroidism.

Tracy S Wang1, Sanziana A Roman, Heather Cox, Mamie Air, Julie Ann Sosa.   

Abstract

BACKGROUND: Thyroid nodules are found in 12-52% of patients with primary hyperparathyroidism (pHPT). With the increasing use of minimally invasive parathyroidectomy (MIP), there is no standard approach for the management of incidental thyroid nodules in pHPT patients.
METHODS: A survey was conducted of the American Association of Endocrine Surgeons. Information was obtained regarding parathyroidectomy practice patterns, including surgical technique, preoperative localization procedures, and algorithms used in the diagnosis/treatment of incidental thyroid nodules.
RESULTS: The survey response rate was 74%. Sixty-seven percent were high-volume parathyroid surgeons (>5/mo); the majority performed MIP. High-volume surgeons were more likely to use Sestamibi/single photon emitted computed tomography for preoperative localization (40% versus 24%; P = 0.011) and to disregard incidentally discovered thyroid nodules <1 cm (41% versus 22%; P = 0.023). They were less likely to evaluate nodules discovered intraoperatively by frozen section (28% versus 41%; P = 0.081), fine-needle aspiration (13% versus 24%; P = 0.078), or thyroidectomy (24% versus 40%; P = 0.03). Surgeons performing open parathyroidectomy were more likely than those who use MIP to biopsy nodules intraoperatively (32% versus 20%; P < 0.05) and perform simultaneous thyroidectomy (30% versus 10%; P < 0.001).
CONCLUSIONS: Experienced endocrine surgeons disagree about the optimal management of incidental thyroid nodules encountered during parathyroidectomy. Our data suggest that high-volume parathyroid surgeons are less aggressive in their evaluation of thyroid pathology in patients with pHPT. Variation in practice among this experienced group implies even greater variation in the broader surgical community, and in the quality and cost of care for patients with pHPT.

Entities:  

Mesh:

Year:  2008        PMID: 19201427     DOI: 10.1016/j.jss.2008.06.013

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  6 in total

1.  How to assess a survey in surgery.

Authors:  Achilleas Thoma; Sylvie D Cornacchi; Forough Farrokhyar; Mohit Bhandari; Charlie H Goldsmith
Journal:  Can J Surg       Date:  2011-12       Impact factor: 2.089

2.  The coexistence of primary hyperparathyroidism and thyroid nodules: should the preoperative work-up of the parathyroid and the thyroid diseases be specifically adjusted?

Authors:  G Scerrino; M Attard; C Lo Piccolo; A Attard; G I Melfa; C Raspanti; M Zarcone; S Bonventre; S Mazzola; G Gulotta
Journal:  G Chir       Date:  2016 May-Jun

3.  Co-existent thyroid disease in patients treated for primary hyperparathyroidism: implications for clinical management.

Authors:  S Ryan; D Courtney; C Timon
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-03-15       Impact factor: 2.503

4.  Surgical management of primary hyperparathyroidism.

Authors:  Stephen Ryan; Danielle Courtney; Julia Moriariu; Conrad Timon
Journal:  Eur Arch Otorhinolaryngol       Date:  2017-10-16       Impact factor: 2.503

5.  Thyroid cancer incidence in simultaneous thyroidectomy with parathyroid surgery.

Authors:  Selman Emirikçi; Beyza Özçınar; Gizem Öner; Nail Omarov; Orhan Ağcaoğlu; Yiğit Soytaş; Nihat Aksakal; Fatih Yanar; Umut Barbaros; Yeşim Erbil
Journal:  Ulus Cerrahi Derg       Date:  2015-08-18

6.  Accessing the influence of 99mTc-Sesta-MIBI-positive thyroid nodules on preoperative localisation studies in patients with primary hyperparathyroidism.

Authors:  Lindsay Hargitai; Maria Schefner; Tatjana Traub-Weidinger; Alexander Haug; Melisa Arikan; Christian Scheuba; Philipp Riss
Journal:  Langenbecks Arch Surg       Date:  2022-01-21       Impact factor: 2.895

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.